Thomas Rohrer
Vice President, Bioconjugation Veranova
Seminars
Tuesday 13th October 2026
Expansion of Bioconjugate Manufacturing Capabilities in a Linker-Payload CDMO
5:30 pm
- Explaining how drug and linker technology will drive future product development of bioconjugate therapeutics
- Implementing internal process development and analytical activities to support bioconjugation services
- Breaking down novel bioconjugate constructed for a European biotechnology company, including preclinical profiles
- Navigating buildout of bioconjugation manufacturing for diverse future payloads
